Standard Glass Secures Rs 40 Cr Investment From Amansa Ahead of IPO

Amansa Investments Limited invested Rs 40 crore in pre-IPO capital through a private placement to Standard Glass Lining Technology Limited, a producer of specialised technical equipment for the chemical and pharmaceutical sectors. After consulting with the top bankers, Standard Glass sold Amansa Investments more than 28.57 lakh equity shares for Rs 140 each, with a premium of Rs 130. According to a Standard Glass news statement on Friday, the Rs 40 crore deal amounts to 1.55% of the company's pre-offer share capital.

As per the July 2024 DRHP (draft red herring prospectus), the Standard Glass Lining Technology IPO, which has a face value of Rs 10 per equity share, consists of both a fresh issuance of shares up to Rs 250 crore and an offer for sale (OFS) of up to 1,84,44,000 equity shares of selling shareholders and promoters. The organisation was given SEBI's final nod on the IPO in October.

Up to 600 crore would be raised by Standard Glass Lining Technology Limited to support its continued development and growth. The IPO comprises an offer for the sale of up to 18.44 million equity shares by our promoters and other shareholders, as well as a new issuance of Rs 250 crore directly to the firm.

The Rs 250 crore that the company will raise will be used for a number of important projects. Of that amount, Rs 10 crore will be used for capital expenditures, specifically to buy new machinery and equipment to increase the production capacity; Rs 130 crore will be used to repay or prepay outstanding debts owed by the company and its wholly-owned subsidiary, S2 Engineering Industry Private Limited; and another Rs 30 crore will be invested in S2 Engineering to fund its capital expenditure needs. The remaining Rs 20 crore will be used for strategic investments, acquisitions, and general corporate purposes.
In addition to providing complete standard operating procedures for chemical and pharmaceutical firms, Standard Glass Lining Technology provides comprehensive solutions that cover design, engineering, production, assembly, installation, and commissioning. Its product offering, is divided into three categories-Reaction Systems, Storage, Separation, and Drying Systems, and Plant, Engineering, and Services-includes necessary machinery for the manufacturing of chemical and pharmaceutical products. The portfolio included over 65 goods and solutions as of March 31, 2024. It said that it has supplied over 11,000 products in the past ten years.

The offer's registrar was KFin Technologies Limited, while the book-running lead managers were IIFL Securities Limited and Motilal Oswal Investment Advisor Limited. The BSE and NSE are where the corporation plans to list its shares.